Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
14.41
-0.07 (-0.48%)
At close: Oct 03, 2025, 3:59 PM
14.75
2.36%
After-hours: Oct 03, 2025, 04:26 PM EDT
-0.48% (1D)
| Bid | 13.49 |
| Market Cap | 101.2M |
| Revenue (ttm) | 188.67M |
| Net Income (ttm) | 5.79M |
| EPS (ttm) | 0.73 |
| PE Ratio (ttm) | 19.74 |
| Forward PE | 160.89 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 14.94 |
| Volume | 34,885 |
| Avg. Volume (20D) | 57,034 |
| Open | 14.58 |
| Previous Close | 14.48 |
| Day's Range | 14.09 - 14.84 |
| 52-Week Range | 5.00 - 18.70 |
| Beta | 0.26 |
| Ex-Dividend Date | n/a |
About ATRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAtara Biotherapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.82%
Atara Biotherapeutics shares are trading higher af...
Unlock content with
Pro Subscription
4 months ago
+15.13%
Atara Biotherapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.
